Tiropramide (INN) is an antispasmodic.[1]
![]() | |
Clinical data | |
---|---|
Other names | N-[3-[4-(2-Diethylaminoethoxy)phenyl]-1-(dipropylamino)-1-oxopropan-2-yl]benzamide |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C28H41N3O3 |
Molar mass | 467.654 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Synthesis
editThe acylation of DL-Tyrosine [556-03-6] (1) with benzoyl chloride gives N,O-dibenzoyl-Tyrosine [14325-35-0] (2). Esterification with n-dipropylamine [142-84-7] (3) via the mixed anhydride method gave N,O-Dibenzoyl-DL-tyrosyl-N',N'-dipropylamide [57227-08-4] (4). Saponification of the ester in base gave N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide [57227-09-5] (5). Ether formation with 2-Chlorotriethylamine [100-35-6] (6) completed the synthesis of Tiropramide (7).
References
edit- ^ Vidal y Plana RR, Cifarelli A, Setnikar I (January 1981). "Mechanism of smooth muscle relaxation by tiropramide". The Journal of Pharmacy and Pharmacology. 33 (1): 19–24. doi:10.1111/j.2042-7158.1981.tb13694.x. PMID 6114146. S2CID 22487894.
- ^ Serradell, MN; de Angelis, L.; Blancafort, P.; Castaer, J.; Tiropramide. Drugs Fut 1982, 7, 6, 413.
- ^ DE2503992 idem Francesco Makovec, Luigi Rovati, Paolo Senin, U.S. patent 4,004,008 (1977 to Rotta Research Laboratorium S.P.A.).